US Patent Issued to Novocure on Nov. 25 for "Reducing electrosensation whilst treating a subject using alternating electric fields by pairing transducer arrays together" (Israeli Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,793, issued on Nov. 25, was assigned to Novocure GmbH (Baar, Switzerland).

"Reducing electrosensation whilst treating a subject using alternating electric fields by pairing transducer arrays together" was invented by Moshe Giladi (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "When treating a subject using alternating electric fields (e.g., using TTFields to treat a tumor, or using alternating electric fields to increase the permeability of the blood brain barrier), some subjects experience an unpleasant electrosensation effect. This electrosensation can be reduced or eliminated by increasing the area of the transducer arrays that is a...